Alloimmunization among transfusion-dependent thalassemia patients.

Area of Science:

• Hematology
• Immunology
• Transfusion Medicine

Background:

• Thalassemia is a significant public health issue in Iran.
• Blood transfusions, while life-saving for thalassemia patients, carry risks like erythrocyte alloimmunization.
• Alloimmunization can complicate transfusion management in these patients.

Purpose of the Study:

• To determine the prevalence of red blood cell alloantibodies in multi-transfused thalassemia patients.
• To identify the specific types of alloantibodies present in these patients.
• To understand the clinical factors associated with alloimmunization.

Main Methods:

• A cohort of 313 multi-transfused thalassemia patients in northeast Iran was studied.
• Patient serum was screened for antibodies using standard serological methods.
• Positive screening results led to antibody identification using a panel of blood group antigens.

Main Results:

• Twelve alloantibodies were detected in 9 patients (2.87% prevalence).
• All identified antibodies were against Rhesus (Rh) blood group antigens (D, C, E).
• Higher alloimmunization rates were observed in females, Rh-negative individuals, and splenectomized patients.

Conclusions:

• Early evaluation and matching of packed red blood cells for Rh (C, E) antigens may reduce alloantibody synthesis.
• This strategy can improve transfusion safety and efficacy for thalassemia patients.
• Further research into alloimmunization patterns in thalassemia is warranted.